BCRX's logo.
Ticker Symbol: BCRX

Biocryst Pharmaceuticals Inc.

$12.10 - 12-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000882796

Company Profile

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 4505 Emperor Blvd Ste 200
CEO: Jon Stonehouse
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $5.88
Change: $0.16 ( 2.80%)
Days Range: $5.68 - $5.98
Beta: 0.89
52wk. High: $14.27
52wk. Low: $5.55
Ytd. Change -45.98%
50 Day Moving Average: $6.76
200 Day Moving Average: $7.45
Shares Outstanding: 189493735

Valuation

Market Cap: 111.4B
PE Ratio: -4.56
EPS (TTM): -1.29

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A